CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Events Archives

Consultation on Drug Reviews: Webinar for Patient Groups

July 9, 2020
Patient groups and other stakeholders are invited to comment on a revised procedure for CADTH’s drug reimbursement review processes (that is, the pan-Canadian Oncology Drug Review, the Common Drug Review, and the Interim Plasma Protein Product Review).  To help patient groups and patients contribute to the consultation, this webinar will h...

Surviving the COVID-19 Infodemic — Can You Trust Dr. Google?

June 23, 2020
According to the World Health Organization, the world is fighting the COVID-19 pandemic on two fronts — the disease itself and a related “info emic” that it says is just as dangerous as the virus. An infodemic is an overwhelming flood of information, misinformation, rumours, and outright scams that make it hard to know what to trust. Misinformat...

Does the Evidence Support the Hype? COVID-19 and Antiviral Treatments

May 29, 2020
The magnitude of the COVID-19 pandemic globally is generating considerable interest in options to prevent infection and minimize the impact if infection occurs. Pre-exposure prophylaxis and post-exposure treatment with a group of drugs called antivirals, sometimes in combination with an antibiotic, have been the subject of public debate and, at ...

Cancellation of the 2020 CADTH Symposium

April 18, 2020 - April 21, 2020
A message from Dr. Brian O’Rourke, CADTH President and CEO, After carefully considering the evolving situation with COVID-19, and keeping in mind the Public Health Agency of Canada’s advice on mass gatherings during the outbreak, we’ve made the difficult decision to cancel our in-person conference, the CADTH Symposium, scheduled to be held in T...